Vadilal Enterprises Intrinsic Value
Vadilal Enterprises intrinsic value. Vadilal Enterprises (VADILENT) median intrinsic value is ₹2958.00 from 3 valuation models (range ₹1972–₹3944), vs current price ₹9860.00 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit VADILENT share price.
VADILENT Valuation Methods Summary — DCF, Graham Number & P/E
Vadilal Enterprises intrinsic value across 3 models vs current price ₹9860.00 — upside/downside and value range per method. Compare with Vadilal Enterprises valuation methods to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹1972.00 | ₹1774.80 - ₹2169.20 | -80.0% | Book Value/Share: ₹40.00, P/B: 1.0x |
| Simple DCF (5Y) | dcf | ₹3944.00 | ₹3155.20 - ₹4732.80 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹2958.00 | ₹2662.20 - ₹3253.80 | -70.0% | DPS: ₹1.50, Target Yield: 3.5% |
VADILENT Intrinsic Value vs Market Price — All Valuation Models
Vadilal Enterprises fair value range ₹1972–₹3944 vs current market price ₹9860.00 across 3 valuation models. Read Vadilal Enterprises dividend policy for the complete payout history and dividend yield track record.
VADILENT Intrinsic Value Analysis — Undervalued or Overvalued?
Vadilal Enterprises median intrinsic value ₹2958.00, current price ₹9860.00 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of VADILENT?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Vadilal Enterprises (VADILENT) is ₹2958.00 (median value). With the current market price of ₹9860.00, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹1972.00 to ₹3944.00, indicating ₹1972.00 - ₹3944.00.
Is VADILENT undervalued or overvalued?
Based on our multi-method analysis, Vadilal Enterprises (VADILENT) appears to be trading above calculated value by approximately 70.0%.
VADILENT Financial Health — Key Ratios vs Industry Benchmarks
Vadilal Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 19.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
VADILENT Cash Flow Quality — Operating & Free Cash Flow
Vadilal Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2016 | ₹28 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |
| March 2015 | ₹15 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |